FIZRX | VMVAX | FIZRX / VMVAX | |
Total Expense Ratio | 1.36 | 0.07 | 1,943% |
Annual Report Gross Expense Ratio | 1.44 | 0.07 | 2,057% |
Fund Existence | 2 years | 14 years | - |
Gain YTD | 5.784 | 5.532 | 105% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 527M | 30.6B | 2% |
Annual Yield % from dividends | 0.33 | 2.26 | 15% |
Returns for 1 year | 0.94 | 9.76 | 10% |
Returns for 3 years | N/A | 28.18 | - |
Returns for 5 years | N/A | 71.82 | - |
Returns for 10 years | N/A | 93.07 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VTEB | 48.56 | 0.06 | +0.12% |
Vanguard Tax-Exempt Bond ETF | |||
EWS | 27.48 | -0.01 | -0.04% |
iShares MSCI Singapore ETF | |||
SZK | 11.76 | -0.01 | -0.08% |
ProShares UltraShort Consumer Staples | |||
AVEE | 61.42 | -0.29 | -0.47% |
Avantis Emerging Markets Sm Cp Eq ETF | |||
FEMB | 28.68 | -0.16 | -0.57% |
First Trust Emerging Mkts Lcl Ccy Bd ETF |